The International Society for CNS Drug Development (ISCDD) was formed in 2002 with the goal of establishing a forum for improvement of methodology in CNS research. ISCDD is a non-profit independent society focused on addressing scientific challenges in CNS drug development, through research and collaboration among stakeholders including academia, industry and government.
Raymond Sanchez Receives ISCDD Leadership Award at ISCDD 2016 Annual Meeting
LAS VEGAS, March 17, 2016 /PRNewswire/ — The International Society for CNS Drug Development (ISCDD) announced today that Raymond Sanchez, M.D., Senior Vice President, Global Clinical Development at Otsuka Pharmaceutical Development & Commercialization, (OPDC), is the recipient of the 2016 ISCDD Award for Leadership at its 14th Annual Meeting. The 2016 ISCDD Award was presented […]
Antony Loebel Receives ISCDD Leadership Award at ISCDD 2015 Annual Meeting
LAS VEGAS, March 17, 2015 /PRNewswire/ — The International Society for CNS Drug Development (ISCDD) announced today thatAntony Loebel, M.D., Executive Vice President and Chief Medical Officer at Sunovion is the recipient of the 2015 ISCDD Award for Leadership at its 13th Annual Meeting. The 2015 ISCDD Award was presented to Dr. Loebel by Dr. George […]
ISCDD Presents John Greist with 2014 ISCDD Award at 12th Annual Meeting
LAS VEGAS, April 11, 2014 /PRNewswire/ — The International Society for CNS Drug Development (ISCDD) has announced that Dr. John H. Greist was the recipient of the 2014 ISCDD Award at its 12th Annual Meeting. The 2014 ISCDD Award was presented to Dr. Greist by Dr. Bill Potter, the current Chairman of the ISCDD Executive Committee, […]
